It is presently unknown whether ATM has a specific role in the acquisition or maintenance of the glycolytic phenotype in cancer cells and more importantly whether there are intersections between the oncogene-driven mitogenic pathways and ATM signaling. The gene discussed is ATM; the disease is cancer.